Bolt Biotherapeutics
NASDAQ:BOLTBolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies for the treatment of cancer. The company's lead product candidate BDC-1001, which is in clinical development for the treatment of patients with human epidermal growth factor receptor 2- positive solid tumors, including breast, colorectal, endometrial, and gastroesophageal cancer. It is also developing BDC-3042, an agonist antibody targeting Dectin-2 for range of tumors, such as head and neck, non-small cell lung, ovarian, triple-negative breast, and other cancer. The company has collaboration agreements with Toray Industries, Genmab A/S, Innovent Biologics, Inc., Bristol-Myers Squibb, and F. Hoffmann-La Roche Ltd; and license agreement with Stanford University. The company was formerly known as Bolt Therapeutics, Inc. and changed its name to Bolt Biotherapeutics, Inc. in July 2015. Bolt Biotherapeutics, Inc. was incorporated in 2015 and is headquartered in Redwood City, California.
Canada Zinc Metals
CVE:CZXCanada Zinc Metals Corp. explores for and evaluates mineral resource properties in Canada. The company primarily explores for zinc-lead-silver base metals deposits. Its flagship property is the Akie property that consists of 46 mineral claims, which cover approximately 116 square kilometers, located in the Paleozoic Selwyn Basin, British Columbia. The company was formerly known as Mantle Resources Inc. and changed its name to Canada Zinc Metals Corp. in September 2008. Canada Zinc Metals Corp. was incorporated in 1988 and is headquartered in Vancouver, Canada.
Genesee & Wyoming
NYSE:GWRGenesee & Wyoming Inc. owns and leases freight railroads. It operates through three segments: North American Operations, Australian Operations, and U.K./European Operations. The company transports various commodities, including agricultural products, autos and auto parts, chemicals and plastics, coal and coke, food and kindred products, lumber and forest products, metallic ores, metals, minerals and stone, petroleum products, pulp and paper, waste, and other commodities. It owns or leases 122 freight railroads, including 105 short line railroads and 2 regional freight railroads located in the United States, 8 short line railroads located in Canada, 3 railroads located in Australia, 1 railroad located in the United Kingdom, 1 railroad in Poland and Germany, and 2 railroads in the Netherlands with a total of approximately 16,200 miles of track. The company also operates 6,200 additional miles of track that is owned or leased by others. In addition, it operates deep sea maritime containers and provides bulk haulage, including coal, aggregates, cement, and infrastructure services. Further, the company provides rail service at approximately 40 ports; rail-ferry service in North America, Australia, and Europe; and contract coal loading and railcar switching for industrial customers. Genesee & Wyoming Inc. was founded in 1899 and is headquartered in Darien, Connecticut.